To Evaluate the Efficacy and Safety of Rapamycin for Crohn's Disease-related Stricture

NCT02675153 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Crohn's Diseases

Interventions

DRUG: Rapamycin

Sponsor

The Second Hospital of Nanjing Medical University